Intra-articular therapy with infliximab in psoriatic arthritis: Efficacy and safety in refractory monoarthritis;Terapia intra-articolare con infliximab nell'artrite psoriasica: Valutazione di efficacia e tollerabilità nel trattamento della monoartrite refrattaria

Reumatismo

Volumn 62, Issue 1, 2010, Pages 46-50

  Bello, S ^a   Bonali, C ^a   Serafino, L ^a   di Giuseppe, P ^a   Minosi, A ^b   Terlizzi, N ^a  

^a POLICLINICO   (Italy)

^b Ospedale A Perrino   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; CYCLOSPORIN A; DICLOFENAC; ETORICOXIB; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; JOINT ASPIRATION; MALE; MONARTHRITIS; PSORIATIC ARTHRITIS; REMISSION; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953696180     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33: 305-15.
2. Ridderstad A, Abedi-Valugerdi M, Möller E. Cytokines in rheumatoid arthritis. Ann Med 1991; 23: 219-23.
3. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 1992; 31: 653-61.
4. Mease PJ. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors. Ann Rheum Dis 2002; 61: 298-304.
5. Nikas SN, Temekonidis TI, Zikou AK, Argyropoulou MI, Efremidis S, Drosos AA. Treatment of resistent rheumatoid arthritis by intra-articular injections with infliximab: a pilot study. Ann. Rheum Dis 2004; 63: 102-3.
6. Schatteman L, Gyselbrecht L, De Clercq L, Mielants H. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of in-fliximab. J Rheumatol 2006; 33: 82-5.
7. Conti F, Ceccarelli F, Priori R, Iagnocco A, Signore A, Valesini G. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with mono-arthritis resistant to local glucocorticoids. Clinical effi-cacy extended to patients on systemic anti-tumor necrosis factor alpha. Ann Rheum Dis 2008; 67: 1787-90.
8. Andonopoulos A.P, Meimaris N, Daoussis D, Bounas A, Yiannopoulos G. Intraarticular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behcet's disease. Clin Exp Rheumatol 2003; 21 (4 Suppl. 30): 557-8.
9. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73.
10. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 55-78.